JPS6479657A - Vital decision of medicine - Google Patents

Vital decision of medicine

Info

Publication number
JPS6479657A
JPS6479657A JP62238006A JP23800687A JPS6479657A JP S6479657 A JPS6479657 A JP S6479657A JP 62238006 A JP62238006 A JP 62238006A JP 23800687 A JP23800687 A JP 23800687A JP S6479657 A JPS6479657 A JP S6479657A
Authority
JP
Japan
Prior art keywords
animal
medicine
protein
plasma
dosed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP62238006A
Other languages
English (en)
Other versions
JPH0565106B2 (ja
Inventor
Hirotaka Oohara
Akio Namimatsu
Hirohide Matsuura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Zoki Pharmaceutical Co Ltd
Original Assignee
Nippon Zoki Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Zoki Pharmaceutical Co Ltd filed Critical Nippon Zoki Pharmaceutical Co Ltd
Priority to JP62238006A priority Critical patent/JPS6479657A/ja
Priority to US07/247,280 priority patent/US4996988A/en
Priority to AT88115581T priority patent/ATE108906T1/de
Priority to DE3850728T priority patent/DE3850728T2/de
Priority to EP88115581A priority patent/EP0308926B1/en
Publication of JPS6479657A publication Critical patent/JPS6479657A/ja
Publication of JPH0565106B2 publication Critical patent/JPH0565106B2/ja
Granted legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
JP62238006A 1987-09-22 1987-09-22 Vital decision of medicine Granted JPS6479657A (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP62238006A JPS6479657A (en) 1987-09-22 1987-09-22 Vital decision of medicine
US07/247,280 US4996988A (en) 1987-09-22 1988-09-21 Method of determining behavior of drugs in living bodies
AT88115581T ATE108906T1 (de) 1987-09-22 1988-09-22 Methode zur bestimmung des verhaltens von medikamenten in lebewesen.
DE3850728T DE3850728T2 (de) 1987-09-22 1988-09-22 Methode zur Bestimmung des Verhaltens von Medikamenten in Lebewesen.
EP88115581A EP0308926B1 (en) 1987-09-22 1988-09-22 Method of determining behaviour of drugs in living bodies

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62238006A JPS6479657A (en) 1987-09-22 1987-09-22 Vital decision of medicine

Publications (2)

Publication Number Publication Date
JPS6479657A true JPS6479657A (en) 1989-03-24
JPH0565106B2 JPH0565106B2 (ja) 1993-09-17

Family

ID=17023739

Family Applications (1)

Application Number Title Priority Date Filing Date
JP62238006A Granted JPS6479657A (en) 1987-09-22 1987-09-22 Vital decision of medicine

Country Status (5)

Country Link
US (1) US4996988A (ja)
EP (1) EP0308926B1 (ja)
JP (1) JPS6479657A (ja)
AT (1) ATE108906T1 (ja)
DE (1) DE3850728T2 (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019131879A1 (ja) * 2017-12-28 2019-07-04 学校法人兵庫医科大学 リポカリン型プロスタグランジンｄ２合成酵素産生促進剤

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6234965B1 (en) * 1998-03-31 2001-05-22 Scientific Learning Corporation Methods and apparatus for improving biochemical based therapy in humans
KR101307999B1 (ko) 2004-12-01 2013-09-12 니폰 조키 세야쿠 가부시키가이샤 건조물 및 그 제조방법
US20060134646A1 (en) * 2004-12-17 2006-06-22 Ansari Aftab A Method for treatment of HIV infection
EP2075341A4 (en) * 2006-09-06 2010-09-08 Nippon Zoki Pharmaceutical Co METHOD FOR THE INVESTIGATION, DETERMINATION OR EVALUATION BY MEANS OF GENE EXPRESSION ANALYSIS
WO2011017835A1 (en) * 2009-08-11 2011-02-17 Nanjing University Preparation method of protein or peptide nanoparticles for in vivo drug delivery by unfolding and refolding
CN115629217A (zh) 2013-04-30 2023-01-20 日本脏器制药株式会社 提取物和含有该提取物的制剂
US20150031004A1 (en) 2013-07-24 2015-01-29 Lumos Labs, Inc. Physically intuitive, real-time, multiple object tracking, planning and divided attention task for enhancing cognition

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU506395A1 (ru) * 1974-06-10 1976-03-15 Всесоюзный научно-исследовательский институт ветеринарной санитарии Способ токсикологического исследовани м са животных, вынужденно забитых при фузариотоксикозе
SU656099A1 (ru) * 1977-09-06 1979-04-05 Научно-Исследовательский Институт Эпидемиологии, Микробиологии И Инфекционных Болезней Способ моделировани реакций клеточной гиперчувствительности
SU1076810A1 (ru) * 1981-05-29 1984-02-29 Институт питания АМН СССР Способ определени безвредности продуктов питани
US4537747A (en) * 1983-03-16 1985-08-27 Chemetrics, Inc. Disposable device for sampling and diluting
US4535786A (en) * 1983-07-25 1985-08-20 Kater John A R Measurement of body fluid chemistry
SU1187793A1 (ru) * 1984-01-31 1985-10-30 Do G Med I Im A M Gorkogo Способ диагностики острого панкреатита
US4677968A (en) * 1986-01-14 1987-07-07 University Of Utah Research Foundation Methods of testing the reaction of various substances on living human skin

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019131879A1 (ja) * 2017-12-28 2019-07-04 学校法人兵庫医科大学 リポカリン型プロスタグランジンｄ２合成酵素産生促進剤
JP6607655B1 (ja) * 2017-12-28 2019-11-20 学校法人兵庫医科大学 リポカリン型プロスタグランジンｄ２合成酵素産生促進剤
JP2020007376A (ja) * 2017-12-28 2020-01-16 学校法人兵庫医科大学 リポカリン型プロスタグランジンｄ２合成酵素産生促進剤
CN111511403A (zh) * 2017-12-28 2020-08-07 学校法人兵库医科大学 脂质运载蛋白型前列腺素d2合成酶产生促进剂
AU2018394182B2 (en) * 2017-12-28 2024-08-08 Hyogo College Of Medicine Lipocalin-type prostaglandin D2 synthase production accelerating agent

Also Published As

Publication number Publication date
DE3850728D1 (de) 1994-08-25
US4996988A (en) 1991-03-05
EP0308926B1 (en) 1994-07-20
JPH0565106B2 (ja) 1993-09-17
EP0308926A2 (en) 1989-03-29
DE3850728T2 (de) 1994-12-22
ATE108906T1 (de) 1994-08-15
EP0308926A3 (en) 1990-07-11

Similar Documents

Publication Publication Date Title
Gale et al. Seizure protection and increased nerve-terminal GABA: delayed effects of GABA transaminase inhibition
AU6933900A (en) Method, reagent and test cartridge for determining clotting time
DE59009462D1 (de) Implantierbare Vorrichtung zur dosierten Abgabe von Medikamenten in den menschlichen Körper.
Walser Progression of chronic renal failure in man
DE69534225D1 (de) Vorrichtung zur verabreichung von medikamenten mit einem mikroprozessor und einem kennzeichenmonitor
DE58905835D1 (de) Vorrichtung zur nadellosen, subkutanen Injektion von Medikamenten.
DK0420332T3 (da) Fremgangsmåde til bestemmelse af det endogene trombinpotentiale af plasma og blod, samt et kit til anvendelse ved fremgangsmåden
NO178682C (no) Fremgangsmåte for å stabilisere blodkoagulasjonsfaktorer, samt kontrollplasma og reagens for å bestemme biologisk aktivitet av blodkoagulasjonsfaktorer
Chakder et al. Evidence for VIP-induced increase in NO production in myenteric neurons of opossum internal anal sphincter
GR3017975T3 (en) Method for detection of anti-rna-antibodies.
ATE86498T1 (de) Verminderung des gehaltes an lipoproteine mit geringer dichte in biologischen fluessigkeiten.
Robinson et al. Variation of plasma immunoreactive parathyroid hormone and calcitonin in normal and hyperparathyroid man during daylight hours
EP0308926A3 (en) Method of determining behavior of drugs in living bodies
ES2099876T3 (es) Procedimiento para la determinacion de anticuerpos de lupus anticoagulante que provocan trombosis.
DE3650368D1 (de) Verwendung von Depogen zur Behandlung von eingeschränktem Blutkreislauf.
FR2357899A1 (fr) Procede de purification d'un antiserum engendre a l'encontre d'un complexe enzyme-inhibiteur faisant partie du systeme de coagulation du sang ou du systeme fibrinolytique active dans le plasma sanguin
Ganley et al. Increased renal tubular cell excretion by patients receiving chronic therapy with gold and with nonsteroidal anti‐inflammatory drugs
SU1163862A1 (ru) Способ лечени больных тиреотоксикозом
Strahan et al. The effect of pituitary posterior lobe extracts on the blood pressure of the fowl.
Cohen et al. Persistence of antipsychotic drug effects and tissue levels
JPS5427339A (en) Information process system for nuclear fuel
Howitt et al. The isoelectric point of serum-globulin as determined by kataphoresis
UA37496A (uk) Спосіб прогнозування індивідуальної чутливості до лазерного випромінювання
Simpson BENJAMIN WATERHOUSE
NO883868D0 (no) Fremgangsmaate for diagnostisering av dsrna-mangeltilstander, samt fremgangsmaate for fremstilling av preparater for diagnostisering og behandling av slike tilstander.

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20070917

Year of fee payment: 14

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080917

Year of fee payment: 15

EXPY Cancellation because of completion of term
FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080917

Year of fee payment: 15